UNSPSC 51372115: Codeine phosphate hemihydrate

This classification denotes an opiate with the molecular formula 2C18H21NO3.H2O.2H3O4P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GSL05Y1MN6, chemically known as 7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol phosphate (1:1) (salt) hemihydrate but more generally known as codeine phosphate, which bears US NIH Compound Identifier 5359227. European Medicines Agency schedules Codeine phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13427MIG.

Most nations, for tariff and trade purposes, schedule codeine phosphate hemihydrate under HS 29391100. SMILES: CN1CC[C@]23C4C5CCC(C4O[C@H]2[C@H](C=C[C@H]3[C@H]1C5)O)OC.CN1CC[C@]23C4C5CCC(C4O[C@H]2[C@H](C=C[C@H]3[C@H]1C5)O)OC.O.OP(=O)(O)O.OP(=O)(O)O.

UNSPSC 51372115 Codeine phosphate hemihydrate is a Commodity code that nominally describes a specific pharmaceutical product, but recent state and local solicitations under this code show little activity aligned with that narrow scope. The single recent opportunity in the dataset—Seminole County, Florida's IFB for naloxone and drug deactivation systems—involves procurement of opioid-overdose reversal agents and harm-reduction equipment rather than codeine phosphate itself. The mismatch suggests either a tagging error in the procurement system or that the code has been applied to related pharmaceutical and public-health products more broadly than its formal definition implies. State and local governments using this code appear to include county health departments and emergency-response authorities focused on substance-abuse mitigation and community health initiatives rather than traditional pharmaceutical supply chains.

Seminole County, Florida is the primary recent issuer under this code. The county posted IFB 60459723LAS on June 30, 2026, requesting 1,900 units of naloxone and 800 safe drug deactivation systems annually for delivery to the Seminole County Community Health Building in Sanford, with quarterly shipment schedules. The response deadline was July 26, 2023—a significant date discrepancy in the record—and bidders were required to include all shipping and delivery costs in their proposals, submit through the county's e-Procurement Portal, and comply with drug-free workplace certification and E-Verify requirements. The initial contract term was two years with a one-year renewal option. No additional recent opportunities under this code appear in the current dataset, indicating limited current procurement velocity for either codeine phosphate or related pharmaceutical products at the state and local level.